Chemical Technology

Addressing System Management Challenges in Oil and Gas Operations

July 21, 2022

Addressing System
Oil and gas operations require 24/7/365 monitoring to
maintain safety, efficiency, and productivity. Unfortunately, the processes and systems involved

Spotlight

Egalet Corporation

Egalet, a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. Egalet has three approved products. Technology Egalet is developing a pipeline of clinical-stage, product candidates including Egalet-002, an abuse-deterrent, extended-release, oral oxycodone formulation for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Guardian Technology can be applied broadly across different classes of pharmaceutical products and can be used to develop combination products that include multiple active pharmaceutical ingredients with similar or different release profiles.

OTHER WHITEPAPERS
news image

The Key to Efficient Carbon Capture: High-Performance Solvents

whitePaper | February 24, 2023

Solvents — specially formulated liquids that extract carbon dioxide from a mixture of other gases — have been used for decades, and are the most proven and mature carbon capture technologies on the market. They have been used in the petrochemical and fertiliser sectors for many years. Conventional solvents for carbon capture are amine-based, with the most common being monoethanolamine (MEA).

Read More
news image

CHEMICAL INHIBITORS TO RAS ONCOPROTEINS:CURRENT LANDSCAPE AND FUTURE OPPORTUNITIES

whitePaper | June 21, 2022

RAS is the most frequently mutated gene family in human cancers that have been considered “undruggable” due to the elusive nature of RAS inhibitors.

Read More
news image

Modeling and Simulation in Fuel Cell Development

whitePaper | October 20, 2022

One possible way to reduce greenhouse gas emissions and slow down climate change is to replace internal combustion engine vehicles with electric vehicles powered by batteries and fuel cells.

Read More
news image

A GREEN ALTERNATIVE TO TRADITIONAL PLASTICS

whitePaper | July 6, 2022

Plastics are found in a wide variety of products, ranging from grocery bags to car bumpers and are composed predominantly of synthetic polymers derived from petroleum.

Read More
news image

Industrial Decarbonization Roadmap

whitePaper | September 19, 2022

The Industrial Decarbonization Roadmap was executed by a core team responsible for all aspects of production including drafting the report, engaging stakeholders, and managing the peer review process.

Read More
news image

Green Chemistry and Contract Synthesis – a Contradiction?

whitePaper | June 17, 2021

The topic of green chemistry is now also a challenge for contract synthesis suppliers. This is because more and more manufacturers of shampoos, detergents, paints, packaging and other consumer products are becoming increasingly concerned about the ecological footprint of their products. The trend is being fueled by consumers, who are increasingly prepared to spend more money on products that are better for the environment. But the political environment is also exerting major pressure on companies.

Read More

Spotlight

Egalet Corporation

Egalet, a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. Egalet has three approved products. Technology Egalet is developing a pipeline of clinical-stage, product candidates including Egalet-002, an abuse-deterrent, extended-release, oral oxycodone formulation for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Guardian Technology can be applied broadly across different classes of pharmaceutical products and can be used to develop combination products that include multiple active pharmaceutical ingredients with similar or different release profiles.

Events